Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Cyclacel, ManRos Therapeutics deal

August 3, 2015 7:00 AM UTC

Cyclacel granted ManRos exclusive, worldwide rights to develop and commercialize oral seliciclib capsules to treat cystic fibrosis (CF). Cyclacel will receive an upfront payment and is eligible to receive milestones and tiered royalties. Cyclacel will provide its clinical data and technical assistance and supply the product to ManRos for clinical trials. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article